本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Dianthus Therapeutics Inc.

104.77
-2.9200-2.71%
盤前104.770.00000.00%08:04 EDT
成交量:47.90萬
成交額:5,032.01萬
市值:58.60億
市盈率:-25.47
高:108.26
開:107.85
低:104.04
收:107.69
52周最高:117.88
52周最低:32.22
股本:5,593.44萬
流通股本:5,585.01萬
量比:0.67
換手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-4.1130
每股收益(LYR):-4.2037
淨資產收益率:-26.07%
總資產收益率:-17.69%
市淨率:5.00
市盈率(LYR):-24.92

資料載入中...

2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/27

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/26

重要事件披露

Form 8-K - Current report
2026/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/09

重要事件披露

Form 8-K - Current report
2026/03/09

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/30

SEC問詢函

Form CORRESP - Correspondence